DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 2:35 PM EDT
Company Participants
Daniel Scavilla – President, CEO & Director
Matthew Garth – Executive VP & CFO
Conference Call Participants
Erin Wilson Wright – Morgan Stanley, Research Division
Presentation
Erin Wilson Wright
Equity Analyst
Good afternoon, everyone. My name is Erin Wright, the health care services analyst at Morgan Stanley. We’re happy to have with us Dentsply Sirona and the management team. We have CEO, Dan Scavilla, if I said that right, and Matt Garth, the CFO. Newly appointed management team is here.
So we’re really excited to have you here and give your views on the strategy and everything kind of going forward. But for more important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/disclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
Question-and-Answer Session
Erin Wilson Wright
Morgan Stanley, Research Division
And with that, I will kick it off with sort of a higher-level question. But just in light of the recent management changes at Dentsply, new CEO, new CFO, both of you here today. Can you just give us some more insight into what the new team is really thinking in terms of strategy here?
Daniel Scavilla
President, CEO & Director
Yes, glad to. And of course, I’m 30 days in, Matt’s just closing out 90 days. So we reserve the right to refine that and go a little bit deeper over time, of course. But at the end of the day, there’s a couple of things to throw out. First off, a team before us, for the most part, was on the right track. And you’re not going to see a radical shift in some of the thinking. There’s things such as common ERP or other things that we would follow and continue to put
Read the full article here
